Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19748665 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Condition: Hypertension
Interventions: Drug: Darusentan;   Drug: Darusentan Placebo

Indicates status has not been verified in more than two years